Skip to main content

Table 4 The FQPA factor determinations for non-dietary exposures

From: Application of the Food Quality Protection Act children’s health safety factor in the U.S. EPA pesticide risk assessments

 FQPA factor for incidental oral exposureFQPA factor for dermal exposureFQPA factor for inhalation exposure
Number of pesticides for which an FQPA factor was assigned for this exposure scenario271627
Number of pesticides for which this exposure scenario has an FQPA factor greater than 1X4511
Percentage of pesticides for which this exposure scenario has an FQPA factor greater than 1X15%31%41%
Which pesticides have an FQPA factor greater than 1X for this scenarioChlorpropham, glufosinate, tebuconazole, thiophanate-methylChlorpropham, glufosinate, iprodione, tebuconazole, thiophanate-methyl2,4-D, chlorothalonil, chlorpropham, cyprodinil, dicamba BAPMA salt, glufosinate, iprodione, tebuconazole, thiabendazole, thiophanate-methyl, trifloxystrobin
1,3-DichloropropeneN/AN/A1X (4 scenarios for different exposure durations: acute, short-term; intermediate-term; and long-term)
2,4-D1X (1 scenario for short- and intermediate-term)N/A10X (1 scenario for all exposure durations)
Acetamiprid1X (2 scenarios for different exposure durations: short- and intermediate-term; and long-term)1X (2 scenarios for different exposure durations: short- and intermediate-term; and long-term)1X (1 scenario for short- and intermediate-term)
Azoxystrobin1X (1 scenario for short- and intermediate-term)N/AN/A
Boscalid1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)
Captan1X (1 scenario for short-term)1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)
Chlorothalonil1X (2 scenarios for different exposure durations: short-term; and intermediate-term)N/A3X and 30X (2 scenarios for different exposure durations: acute inhalation with 3X FQPA factor; and short- and intermediate-term inhalation with 30X FQPA factor)
Chlorpropham10X (1 scenario for short- and intermediate-term)10X (1 scenario for short- and intermediate-term)10X (1 scenario for short- and intermediate-term)
Clothianidin1X (1 scenario for short-term)1X (1 scenario for all durations)1X (1 scenario for all durations)
Cyprodinil1X (1 scenario for short-term)N/A10X (1 scenario for short- and intermediate-term)
Dicamba1X (1 scenario for short- and intermediate-term)N/A2 scenarios: 1X for short-, intermediate- and long-term inhalation scenario for dicamba acid; 10X for short-, intermediate- and long-term inhalation scenario for dicamba BAPMA salt
Dimethomorph1X (1 scenario for short-term)N/AN/A
Fenhexamid1X (1 scenario for short- and intermediate-term)N/A1X (1 scenario for short- and intermediate-term)
Fludioxonil1X (1 scenario for short- and intermediate-term)N/A1X (1 scenario for short- and intermediate-term)
Fluopicolide1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)
Glufosinate10X (1 scenario for short- and intermediate-term)10X (1 scenario for short- and intermediate-term)10X (1 scenario for acute, short- and intermediate-term)
Glyphosate1X (1 scenario for short- and intermediate-term)N/AN/A
Imidacloprid1X (1 scenario for all durations)1X (1 scenario for all durations)1X (1 scenario for all durations)
IprodioneN/A10X (1 scenario for dermal and inhalation, short- and intermediate-term)
Metalaxyl/Mefenoxam1X (1 scenario for short- and intermediate-term)N/A1X (1 scenario for short- and intermediate-term)
Metolachlor1X (1 scenario for short-term)1X (1 scenario for short- and intermediate-term exposure for children)1X (1 scenario for short- and intermediate-term)
Paraquat1X (1 scenario for short-term)1X (1 scenario for short-term)1X (1 scenario for short-term)
Pendimethalin1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)
Pyraclostrobin1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)
PyrimethanilN/A1X (1 scenario for short- and intermediate-term)1X (1 scenario for short- and intermediate-term)
Spinetoram1X (1 scenario for short- and intermediate-term)N/A1X (1 scenario for short- and intermediate-term)
Tebuconazole3X (1 scenario for short-term)3X (1 scenario for short-term)3X (1 scenario for short-term)
Thiabendazole1X (2 scenarios, for short- and intermediate-term exposure for children and for short- and intermediate-term exposure for adults)N/A10X (1 scenario for short- and intermediate-term)
Thiophanate-methyl3X (1 scenario for short- and intermediate-term)3X (2 scenarios for short- and intermediate-term, and for long-term exposures)3X (2 scenarios for short- and intermediate-term, and for long-term exposures)
Trifloxystrobin1X (1 scenario for short-term)N/A10X (1 scenario for all durations)
  1. N/A not available, indicating that an FQPA factor was not assigned for this exposure scenario